Heather D. Turner's most recent trade in Terns Pharmaceuticals Inc was a trade of 64,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 18, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Terns Pharmaceuticals Inc | Heather D. Turner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 64,000 | 64,000 | - | - | Stock Option (Right to Buy) |